XML 57 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Summary of segment performance
The following table reflects adjustments to previously reported costs in our Unallocated segment, that are now allocated to our CAG, Water, LPD and Other segments for the three and nine months ended September 30, 2019, respectively:
(in thousands)Three Months Ended September 30, 2019
CAGWaterLPDOtherUnallocated
Cost of sales$(428)$(19)$(24)$(10)$481 
Gross profit428 19 24 10 (481)
Operating Expenses:
Sales and marketing$211 $$12 $— $(232)
General and administrative2,472 105 131 1,058 (3,766)
Research and development4,544 20 25 — (4,589)
Total operating expenses$7,227 $134 $168 $1,058 $(8,587)
Income from operations$(6,799)$(115)$(144)$(1,048)$8,106 

(in thousands)Nine Months Ended September 30, 2019
CAGWaterLPDOtherUnallocated
Cost of sales$(266)$(12)$(15)$(6)$299 
Gross profit266 12 15 (299)
Operating Expenses:
Sales and marketing$322 $14 $18 $— $(354)
General and administrative1,377 (114)(122)2,222 (3,363)
Research and development12,062 39 49 — (12,150)
Total operating expenses$13,761 $(61)$(55)$2,222 $(15,867)
Income from operations$(13,495)$73 $70 $(2,216)$15,568 
    
The following is a summary of segment performance:
For the Three Months Ended September 30,
CAGWaterLPDOtherConsolidated Total
2020
Revenue$638,017 $33,272 $36,971 $13,529 $721,789 
Income from operations$139,434 $15,243 $10,505 $6,674 $171,856 
Interest expense, net(7,902)
Income before provision for income taxes163,954 
Provision for income taxes17,633 
Net income146,321 
Less: Net income attributable to noncontrolling interest102 
Net income attributable to IDEXX Laboratories, Inc. stockholders$146,219 
2019
Revenue$533,130 $34,906 $31,370 $5,897 $605,303 
Income from operations$117,691 $16,930 $4,850 $331 $139,802 
Interest expense, net(7,004)
Income before provision for income taxes132,798 
Provision for income taxes23,960 
Net income108,838 
Less: Net income attributable to noncontrolling interest
Net income attributable to IDEXX Laboratories, Inc. stockholders$108,837 
(in thousands)For the Nine Months Ended September 30,
CAGWaterLPDOtherConsolidated Total
2020     
Revenue$1,756,113 $95,537 $103,369 $30,698 $1,985,717 

Income from operations$426,062 $43,383 $28,417 $11,567 $509,429 
Interest expense, net(24,880)
Income before provision for income taxes484,549 
Provision for income taxes77,376 
Net income407,173 
Less: Net income attributable to noncontrolling interest187 
Net income attributable to IDEXX Laboratories, Inc. stockholders$406,986 

2019
Revenue$1,589,397 $99,980 $95,980 $16,105 $1,801,462 

Income from operations$370,600 $47,467 $17,707 $1,441 $437,215 
Interest expense, net(23,503)
Income before provision for income taxes413,712 
Provision for income taxes76,464 
Net income337,248 
Less: Net income attributable to noncontrolling interest24 
Net income attributable to IDEXX Laboratories, Inc. stockholders$337,224